DATELINE: Kinshasa, DRC – Friday, 2026-05-22 LEDE: The World Health Organization (WHO) has escalated the risk assessment for the Ebola outbreak in the Democratic Republic of Congo (DRC) to ‘very high’at the national level, citing the Bundibugyo strain of the virus with no proven vaccine and a fatality rate of approximately one-third. NUT GRAF: As scientists at Oxford University work on a new vaccine, the urgency to contain the outbreak grows, with the WHO and local authorities scaling up efforts. Kinshasa, DRC – The World Health Organization (WHO) has announced that the risk of the Ebola outbreak in the Democratic Republic of Congo (DRC) has been raised to ‘very high’at the national level, reflecting the gravity of the situation.
This critical assessment comes as the DRC faces its 17th Ebola outbreak, with the current crisis marked by the presence of the rare Bundibugyo strain of the virus, which has no proven vaccine or treatment available.
The WHO’s announcement indicates that as of the latest report, there have been 177 suspected deaths and 750 suspected cases of Ebola in the DRC.
The Bundibugyo strain, while less deadly than other Ebola species, poses significant challenges due to its rarity, with fewer tools available to combat it.
Amid these daunting statistics, Oxford University scientists are working on a new Ebola vaccine, leveraging the same technology used for the AstraZeneca Covid vaccine. This potential vaccine could be ready for clinical trials within two to three months, offering a glimmer of hope in the ongoing crisis.
The DRC’s battle with Ebola is not new; the country was the site of the virus’s discovery in 1976.
This latest outbreak underscores the challenges faced by the region, including a remote and densely populated area, combined with insecurity, high population and trade movements, and a humanitarian crisis.
The BBC has highlighted the complex factors contributing to the DRC’s vulnerability to outbreaks, including a mix of environmental, social, and political factors. Reuters reports that the WHO is scaling up support to the governments of the DRC and Uganda, focusing on surveillance, contact tracing, clinical preparedness, and community engagement.
As the situation unfolds, unanswered questions remain, such as the current status of the Oxford University vaccine and the effectiveness of the containment efforts by the WHO and local authorities in the DRC.
Additionally, the long — term implications of this outbreak for public health in the DRC and the wider region are a matter of significant concern. KICKER: With the Ebola outbreak in the DRC reaching ‘very high’risk status, the global community watches with bated breath as the WHO and local authorities intensify their efforts to contain the virus.
The success of the Oxford University vaccine and the resilience of the DRC’s healthcare system will be crucial in determining the outcome of this critical situation. Who.
*Additional reporting by ImNews | Sources consulted: 5*
—
This original article was produced by the ImNews editorial team
Source: Google News v2
